See every side of every news story
Published loading...Updated

The Myth of All-American Drugs and What Trump’s Tariffs Miss About Pharma Supply Chains

UNITED STATES, JUL 22 – Trump claims trade restrictions will compel pharmaceutical firms to cut U.S. drug prices linked to the lowest international rates under his most favored nation policy.

  • During a White House event on Tuesday, Trump announced the 'most favored nation' policy and warned of trade measures if companies and countries refuse to comply.
  • Driven by steep drug expenses in the U.S., the May executive order prompted a 30-day deadline for drugmakers to lower prices or face new payment caps, the May order.
  • Following the outlandish percentages, social media users ridiculed the plan as mathematically impossible.
  • Industry leaders told EU Commission President Ursula von der Leyen that around 30 CEOs warned of a £100 billion investment loss without regulatory changes, with pharmaceutical companies cautioning tariffs could jeopardize European investment.
  • Then Health and Human Services Secretary Robert F. Kennedy Jr. must develop rules tying U.S. drug payments to lower foreign prices if deals fail, and Trump said `we reserve our right to use regulatory authority to ensure change endures.
Insights by Ground AI
Does this summary seem wrong?

19 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources are Center
50% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

UOL broke the news in Brazil on Tuesday, July 22, 2025.
Sources are mostly out of (0)